Enacted in 2013, the Drug Supply Chain Security Act (DSCSA) is a U.S. federal law designed to secure the life sciences value chain and protect patient safety. The regulation establishes a clear framework for achieving an interoperable, electronic system to identify and trace prescription drugs at the package level across the entire supply chain, significantly impacting pharmaceutical manufacturers, distributors and dispensers. This helps stakeholders proactively detect harmful and counterfeit drugs before entering the U.S. market.
An exemption has been extended to support the continued implementation of solutions complying with DSCSA requirements. Those eligible for the exemption include:
As DSCSA solution implementation becomes more established, ensuring seamless product verification is more critical than ever. Our cutting-edge Software-as-a-Service (SaaS) platform, Movilitas.Cloud, offers compliance in just a few steps and simplifies serialization, guaranteeing product authenticity and safety across the supply chain.
Why Choose Movilitas.Cloud?
Ensure your organization is fully prepared for DSCSA compliance with our comprehensive readiness checklist.
As regulations for serialization and demands for product traceability grow, so will the value of integrated technologies for tracking and tracing. The strong technical expertise, profound industry knowledge and successful delivery record of our Digital Supply Chain specialists makes IndX a power player in the arena of serialized manufacturing and logistics. Within the Engineering Industries eXcellence technology portfolio for supply chain, Movilitas.Cloud is our proprietary Software-as-a-Service solution that makes serialization and compliance simple and efficient. With multilingual capabilities and a global team providing ongoing support, we continuously strive to fulfill our mission of helping companies meet the demands of today’s dynamic economy with a quick step-by-step approach.
